IGM Biosciences (IGMS) Stock Statistics & Valuation Metrics

IGM Biosciences has a market cap or net worth of ―. The enterprise value is ―.

IGM Biosciences has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

IGM Biosciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of IGM Biosciences is ―. IGM Biosciences’s PEG ratio is ―.

In the last 12 months, IGM Biosciences had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

IGM Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

IGM Biosciences upcoming earnings date is ―, ―.

IGM Biosciences as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, IGM Biosciences has paid ― in taxes.

IGM Biosciences EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

IGM Biosciences has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for IGM Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―